Carlsmed, Inc.
NASDAQ: CARL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Information Technology Services
- CEO
- Michael Cordonnier
- Employees
- 127
- Headquarters
- Carlsbad, United States
- IPO year
- 2025
- Market cap
- $318.3M
- Website
- https://www.carlsmed.com
Loading CARL…
Loading profile data…Frequently asked questions about CARL
What does Carlsmed, Inc. (CARL) do?
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorith...
Where does CARL trade?
Carlsmed, Inc. (CARL) trades on the NASDAQ.
What sector is CARL in?
Carlsmed, Inc. (CARL) operates in the Healthcare sector, specifically in the Information Technology Services industry.
Who is the CEO of Carlsmed, Inc.?
Michael Cordonnier is the chief executive officer of Carlsmed, Inc. (CARL).
Where is Carlsmed, Inc. headquartered?
Carlsmed, Inc. is headquartered in United States.
Does CARL pay a dividend?
Carlsmed, Inc. (CARL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CARL go public?
Carlsmed, Inc. (CARL) completed its initial public offering in 2025.